- Home
- OCFC vs MDXG Comparison
OCFC vs MDXG Comparison
Compare OCFC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFC
- MDXG
- Stock Information
- Founded
- OCFC 1902
- MDXG 2006
- Country
- OCFC United States
- MDXG United States
- Employees
- OCFC N/A
- MDXG N/A
- Industry
- OCFC Major Banks
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- OCFC Finance
- MDXG Health Care
- Exchange
- OCFC Nasdaq
- MDXG Nasdaq
- Market Cap
- OCFC 1.1B
- MDXG 1.2B
- IPO Year
- OCFC 1996
- MDXG N/A
- Fundamental
- Price
- OCFC $17.01
- MDXG $7.60
- Analyst Decision
- OCFC Hold
- MDXG Strong Buy
- Analyst Count
- OCFC 4
- MDXG 3
- Target Price
- OCFC $21.50
- MDXG $12.00
- AVG Volume (30 Days)
- OCFC 275.7K
- MDXG 535.9K
- Earning Date
- OCFC 04-17-2025
- MDXG 04-29-2025
- Dividend Yield
- OCFC 4.69%
- MDXG N/A
- EPS Growth
- OCFC N/A
- MDXG N/A
- EPS
- OCFC 1.65
- MDXG 0.28
- Revenue
- OCFC $375,233,000.00
- MDXG $348,879,000.00
- Revenue This Year
- OCFC N/A
- MDXG $10.09
- Revenue Next Year
- OCFC $13.08
- MDXG $11.77
- P/E Ratio
- OCFC $10.35
- MDXG $26.93
- Revenue Growth
- OCFC N/A
- MDXG 8.52
- 52 Week Low
- OCFC $14.03
- MDXG $5.47
- 52 Week High
- OCFC $21.87
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- OCFC 43.52
- MDXG 38.98
- Support Level
- OCFC $16.84
- MDXG $7.84
- Resistance Level
- OCFC $17.50
- MDXG $8.12
- Average True Range (ATR)
- OCFC 0.50
- MDXG 0.24
- MACD
- OCFC 0.04
- MDXG -0.02
- Stochastic Oscillator
- OCFC 29.81
- MDXG 24.05
About OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management services.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.